About: covid:PMC7397938

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7397938 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Li, Yi Niu, Peihua Tan, Wenjie Huang, Baoying Ye, Fei Ma, Jing Peng, Feng Tan, Xin Xie, Jun Tang, Wei Zheng, Fang Zhou, Ning Xu, Yun Xie, Yuanlin Zhou, Zhiguo Zuo, Qi Cai, Chunlin Gong, Guozhong Huang, Yaxiong Jiang, Yongfang Wang, Wenlong Xiao, Xinqiang Zhou, Yanwen Zhou, Zhiguang
is schema:about of	named entity 'Patients' named entity 'Open-label' named entity 'WHO' named entity 'homology' named entity 'Lopinavir/Ritonavir' named entity 'virus' named entity 'COVID-19' named entity 'Ritonavir' named entity 'statistically significant' named entity 'Lopinavir/Ritonavir' named entity 'Lopinavir/Ritonavir' named entity 'viral shedding' named entity 'human interferon' named entity 'COVID' named entity 'antiviral treatment' named entity 'Fang Zheng' named entity 'RT-PCR' named entity 'fatigue' named entity 'DNA shuffling' named entity 'cytopathic effects' named entity 'null hypothesis' named entity 'inhalation' named entity 'antiviral treatment' named entity 'cDNA' named entity 'clearance rate' named entity 'cDNA' named entity 'SARS-CoV-2' named entity 'Lopinavir/Ritonavir' named entity 'protein' named entity 'SARS-CoV-2' named entity 'EC50' named entity 'Kaletra' named entity 'SARS virus' named entity 'adenovirus' named entity 'Lopinavir/Ritonavir' named entity 'RT-PCR' named entity 'molecule' named entity 'EC50' named entity 'Center for Disease Control and Prevention' named entity 'assay' named entity 'HBeAg' named entity 'protein' named entity 'symptom' named entity 'sample size' named entity 'adverse events' named entity 'Vero E6' named entity 'cross-reaction' named entity 'binomial distribution' named entity 'chronic hepatitis B' named entity 'treatment groups' named entity 'assay' named entity 'Lopinavir/Ritonavir' named entity 'Lopinavir/Ritonavir' named entity 'fraction of inspired oxygen' named entity 'cDNA' named entity 'COVID' named entity 'Lopinavir/Ritonavir' named entity 'SARS' named entity 'Lopinavir/Ritonavir' named entity 'SARS-CoV-2' named entity 'Incubation' named entity 'SARS-CoV' named entity 'DNA Shuffling' named entity 'half-maximal' named entity 'symptom' named entity 'randomized trial' named entity 'DNA shuffling' named entity 'molecule' named entity 'antiviral drugs' named entity 'SLAN' named entity 'primary endpoint' named entity 'antiviral treatment' named entity 'cDNA' named entity 'SARS-CoV-2' named entity 'cDNA library' named entity 'Lopinavir/Ritonavir'

Attributes

Values

Creator

Li, Yi
Niu, Peihua
Tan, Wenjie
Huang, Baoying
Ye, Fei
Ma, Jing
Peng, Feng
Tan, Xin
Xie, Jun
Tang, Wei
Zheng, Fang
Zhou, Ning
Xu, Yun
Xie, Yuanlin
Zhou, Zhiguo
Zuo, Qi
Cai, Chunlin
Gong, Guozhong
Huang, Yaxiong
Jiang, Yongfang
Wang, Wenlong
Xiao, Xinqiang
Zhou, Yanwen
Zhou, Zhiguang

is schema:about of

named entity 'Patients'
named entity 'Open-label'
named entity 'WHO'
named entity 'homology'
named entity 'Lopinavir/Ritonavir'
named entity 'virus'
named entity 'COVID-19'
named entity 'Ritonavir'
named entity 'statistically significant'
named entity 'Lopinavir/Ritonavir'
named entity 'Lopinavir/Ritonavir'
named entity 'viral shedding'
named entity 'human interferon'
named entity 'COVID'
named entity 'antiviral treatment'
named entity 'Fang Zheng'
named entity 'RT-PCR'
named entity 'fatigue'
named entity 'DNA shuffling'
named entity 'cytopathic effects'
named entity 'null hypothesis'
named entity 'inhalation'
named entity 'antiviral treatment'
named entity 'cDNA'
named entity 'clearance rate'
named entity 'cDNA'
named entity 'SARS-CoV-2'
named entity 'Lopinavir/Ritonavir'
named entity 'protein'
named entity 'SARS-CoV-2'
named entity 'EC50'
named entity 'Kaletra'
named entity 'SARS virus'
named entity 'adenovirus'
named entity 'Lopinavir/Ritonavir'
named entity 'RT-PCR'
named entity 'molecule'
named entity 'EC50'
named entity 'Center for Disease Control and Prevention'
named entity 'assay'
named entity 'HBeAg'
named entity 'protein'
named entity 'symptom'
named entity 'sample size'
named entity 'adverse events'
named entity 'Vero E6'
named entity 'cross-reaction'
named entity 'binomial distribution'
named entity 'chronic hepatitis B'
named entity 'treatment groups'
named entity 'assay'
named entity 'Lopinavir/Ritonavir'
named entity 'Lopinavir/Ritonavir'
named entity 'fraction of inspired oxygen'
named entity 'cDNA'
named entity 'COVID'
named entity 'Lopinavir/Ritonavir'
named entity 'SARS'
named entity 'Lopinavir/Ritonavir'
named entity 'SARS-CoV-2'
named entity 'Incubation'
named entity 'SARS-CoV'
named entity 'DNA Shuffling'
named entity 'half-maximal'
named entity 'symptom'
named entity 'randomized trial'
named entity 'DNA shuffling'
named entity 'molecule'
named entity 'antiviral drugs'
named entity 'SLAN'
named entity 'primary endpoint'
named entity 'antiviral treatment'
named entity 'cDNA'
named entity 'SARS-CoV-2'
named entity 'cDNA library'
named entity 'Lopinavir/Ritonavir'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software